Telesis Bio Stock Scheduled to Reverse Split on Thursday, May 9th (NASDAQ:TBIO)

Telesis Bio, Inc. (NASDAQ:TBIO) shares are scheduled to reverse split on the morning of Thursday, May 9th. The 1-18 reverse split was announced on Thursday, May 9th. The number of shares owned by shareholders will be adjusted after the market closes on Thursday, May 9th.

Telesis Bio Trading Down 10.0 %

Shares of TBIO stock traded down $0.03 on Tuesday, hitting $0.31. The company had a trading volume of 808,045 shares, compared to its average volume of 575,848. The firm has a market cap of $9.21 million, a P/E ratio of -0.19 and a beta of 1.93. The stock’s 50-day moving average is $0.44 and its two-hundred day moving average is $0.45. The company has a debt-to-equity ratio of 22.76, a quick ratio of 3.22 and a current ratio of 3.71. Telesis Bio has a twelve month low of $0.28 and a twelve month high of $3.01.

Telesis Bio (NASDAQ:TBIO) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.23) earnings per share for the quarter, beating the consensus estimate of ($0.25) by $0.02. The company had revenue of $6.98 million during the quarter. Telesis Bio had a negative return on equity of 176.47% and a negative net margin of 173.78%.

About Telesis Bio

Telesis Bio, Inc, a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. The company offers BioXp 3250 system and BioXp 9600 system, that empower researchers to go from a digital DNA sequence to endpoint-ready synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) with onboard next generation sequencing (NGS) library preparation; BioXp portal, an online portal that offers an intuitive guided workflow and design tools for building new DNA sequences and assembling them into vectors of choice, as well as mRNA constructs; and BioXp De Novo kits which contains the necessary building blocks and reagents, including proprietary gibson assembly branded reagents, for specific synthetic biology workflow applications.